DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Modi S, Tsurutani J, Tamura K, Park H, Sagara Y, Murthy R. et al.
Abstract P6-17-02: Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-low expressing breast cancer: Updated results of a large phase 1 study.
Cancer Res 2019;
79: P6-17-02
We do not assume any responsibility for the contents of the web pages of other providers.